19-1219356-T-G
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000455.5(STK11):c.407T>G(p.Met136Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M136T) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000455.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| STK11 | NM_000455.5 | MANE Select | c.407T>G | p.Met136Arg | missense | Exon 3 of 10 | NP_000446.1 | ||
| STK11 | NM_001407255.1 | c.407T>G | p.Met136Arg | missense | Exon 3 of 9 | NP_001394184.1 | |||
| STK11 | NR_176325.1 | n.1674T>G | non_coding_transcript_exon | Exon 4 of 11 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| STK11 | ENST00000326873.12 | TSL:1 MANE Select | c.407T>G | p.Met136Arg | missense | Exon 3 of 10 | ENSP00000324856.6 | ||
| STK11 | ENST00000652231.1 | c.407T>G | p.Met136Arg | missense | Exon 3 of 9 | ENSP00000498804.1 | |||
| STK11 | ENST00000585748.3 | TSL:3 | c.35T>G | p.Met12Arg | missense | Exon 5 of 12 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 15863673, 11389158)
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.M136R variant (also known as c.407T>G), located in coding exon 3 of the STK11 gene, results from a T to G substitution at nucleotide position 407. The methionine at codon 136 is replaced by arginine, an amino acid with similar properties. This variant was reported in individual(s) with features consistent with Peutz-Jeghers syndrome (Olschwang S et al. J Med Genet, 2001 Jun;38:356-60; Ambry internal data). Other variant(s) at the same codon, p.M136T (c.407T>C), have been identified in individual(s) with features consistent with Peutz-Jeghers syndrome (External communication; Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at